Evidence map›Paper›PMID 32582701›Full record

ArticleFrontiers in cell and developmental biology2020

CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma.

Nattawan Suwannakul, Ning Ma, Kaoru Midorikawa, Shinji Oikawa, Hatasu Kobayashi, Feng He, Shosuke Kawanishi, Mariko Murata

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Pleiotropic effects of DCLK1 in cancer and cancer stem cells.Frontiers in molecular biosciences · 2022
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nattawan SuwannakulDepartment of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Ning MaGraduate School of Health Science, Suzuka University of Medical Science, Suzuka, Japan.
Kaoru MidorikawaDepartment of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Shinji OikawaDepartment of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Hatasu KobayashiDepartment of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Feng HeDepartment of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Shosuke KawanishiFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan.
Mariko MurataDepartment of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Mie University · JPSuzuka University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer stem cellCD44 variant 9cholangiocarcinomaepithelial-mesenchymal transitionWnt/β-catenin

Identifiers

PMID32582701
PMCPMC7283556
OpenAlexW3028348248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.